Literature DB >> 26921625

The "love-hate" relationship between osteoclasts and bone matrix.

Nadia Rucci1, Anna Teti2.   

Abstract

Osteoclasts are unique cells that destroy the mineralized matrix of the skeleton. There is a "love-hate" relationship between the osteoclasts and the bone matrix, whereby the osteoclast is stimulated by the contact with the matrix but, at the same time, it disrupts the matrix, which, in turn, counteracts this disruption by some of its components. The balance between these concerted events brings about bone resorption to be controlled and to contribute to bone tissue integrity and skeletal health. The matrix components released by osteoclasts are also involved in the local regulation of other bone cells and in the systemic control of organismal homeostasis. Disruption of this regulatory loop causes bone diseases, which may end up with either reduced or increased bone mass, often associated with poor bone quality. Expanding the knowledge on osteoclast-to-matrix interaction could help to counteract these diseases and improve the human bone health. In this article, we will present evidence of the physical, molecular and regulatory relationships between the osteoclasts and the mineralized matrix, discussing the underlying mechanisms as well as their pathologic alterations and potential targeting.
Copyright © 2016 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone matrix; Bone resorption; Integrin; Osteoclast

Mesh:

Year:  2016        PMID: 26921625     DOI: 10.1016/j.matbio.2016.02.009

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  13 in total

1.  Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.

Authors:  Maiko Omi; Vesa Kaartinen; Yuji Mishina
Journal:  J Biol Chem       Date:  2019-10-16       Impact factor: 5.157

Review 2.  Extracellular matrix: The driving force of mammalian diseases.

Authors:  Renato V Iozzo; Maria A Gubbiotti
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

3.  Role of osteoclasts in oral homeostasis and jawbone diseases.

Authors:  Maiko Omi; Yuji Mishina
Journal:  Oral Sci Int       Date:  2020-07-21

4.  Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.

Authors:  Yuting Liu; Donghao Shang
Journal:  Mol Cell Biochem       Date:  2019-12-17       Impact factor: 3.396

5.  Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Larry J Suva; Dana Gaddy; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 6.  Peripheral Blood Mononuclear Cells (PBMCs) to Dissect the Underlying Mechanisms of Bone Disease in Chronic Kidney Disease and Rare Renal Diseases.

Authors:  Irma Machuca-Gayet; Justine Bacchetta; Julie Bernardor; Candide Alioli; Marie-Noelle Meaux; Olivier Peyruchaud
Journal:  Curr Osteoporos Rep       Date:  2021-11-13       Impact factor: 5.096

Review 7.  Switching Homes: How Cancer Moves to Bone.

Authors:  Marco Ponzetti; Nadia Rucci
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

8.  Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications.

Authors:  Mattia Capulli; Antonio Maurizi; Annabel Curle; Rajvi Patel; Argia Ucci; Juliana Alves Côrtes; Harriet Oxford; Shireen R Lamandé; John F Bateman; Nadia Rucci; Anna Teti
Journal:  Bone Res       Date:  2019-06-11       Impact factor: 13.567

Review 9.  Relevance of Notch Signaling for Bone Metabolism and Regeneration.

Authors:  Tobias M Ballhause; Shan Jiang; Anke Baranowsky; Sabine Brandt; Peter R Mertens; Karl-Heinz Frosch; Timur Yorgan; Johannes Keller
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

10.  oxLDL inhibits differentiation and functional activity of osteoclasts via scavenger receptor-A mediated autophagy and cathepsin K secretion.

Authors:  Damilola Dawodu; Margret Patecki; Jan Hegermann; Inna Dumler; Hermann Haller; Yulia Kiyan
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.